https://www.selleckchem.com/pr....oducts/ne-52-qq57.ht
To report early safety and efficacy of Descemet stripping only (DSO) supplemented with ripasudil. A pre-post clinical trial with a historical control group for time to heal and cell count parameters. The study received ethics approval and was conducted with oversight of a data safety monitoring board. All enrolled patients had a superior endothelial cell count of 1000 cells/mm2 and were symptomatic from the presence of central guttata degrading vision and/or producing glare. DSO was carried out with a peeling technique and not co
Like
Comment
Share
